Werewolf Therapeutics (HOWL) Financials

$0.98

$-0.01 (-1.29%)

As on 11-Sep-2026 13:36EDT

Market cap

$47 Mln

Revenue (TTM)

$21 Mln

P/E Ratio

--

P/B Ratio

2.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	21.00	--	1.89	19.94	16.40	4.15
Cost of Revenue	3.25	1.63	1.81	1.76	2.51	0.74
Gross Profit	17.75	-1.63	0.07	18.18	16.40	-0.74
Operating Expenses	43.72	59.04	73.67	58.68	72.46	50.09
Operating Profit (EBIT)	-25.57	-60.68	-73.59	-40.50	-56.06	-50.09
Other Income	--	--	--	--	2.25	0.10
Profit before Tax	-34.61	-60.82	-70.52	-37.37	-53.81	-49.98
Provision for Tax	--	--	--	1.60	-2.25	-0.22
Profit after Tax (Net Income)	-34.61	-60.82	-70.52	-37.37	-51.56	-49.77
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-53.81	101.96

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	16.29	24.81	73.39	111.37	122.34	152.79
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	8.44	38.36	44.08	13.92	14.59
Current Liabilities	7.86	36.15	15.18	19.38	23.99	11.87
Total Liabilities	32.02	69.40	126.93	174.83	160.25	179.25

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	1.26	10.81	13.86	36.46	20.05	18.18
Current Assets	22.89	58.59	113.07	138.37	140.20	161.07
Total Assets	32.02	69.40	126.93	174.83	160.25	179.25
Total Debt*	--	9.44	37.09	51.92	14.68	15.66
Net Current Assets	15.03	22.44	97.89	118.99	116.21	149.19

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-60.29	-56.19	-32.61	-40.60	-42.88
Cash Flow from Investing Activities	--	--	-0.25	-0.77	-3.61	-0.50
Cash from Financing Activities	--	6.03	13.08	58.43	15.91	109.43
Net Cash Inflow / Outflow	--	--	--	--	-28.30	66.05

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.73	-1.30	-1.59	-1.02	-1.68	-1.82
Cash EPS ($)	--	-1.26	-1.54	-0.97	-1.64	-1.82
Adjusted Book Value ($)	--	0.53	1.65	3.05	3.98	5.60
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.29	-1.26	-0.89	-1.32	-1.57
Free Cash Flow per Share ($)	--	-1.29	-1.27	-0.91	-1.44	-1.59

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-84.06	-51.51	-24.89	-33.76	-38.25
ROE (%)	-168.45	-123.88	-76.33	-31.98	-37.48	-41.13
ROA (%)	-49.53	-61.96	-46.74	-22.30	-30.38	-36.11
EBIT Margin (%)	-122.23	--	-3,493.85	-171.63	-341.78	-1,207.50
Net Margin (%)	-164.82	--	-3,740.85	-187.37	-276.53	-1,170.44
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-1.00	-0.91	0.22	2.95	--
EBIT Growth (%)	62.29	15.66	-92.41	38.94	-11.92	-233.03
Net Profit Growth (%)	52.68	13.75	-88.70	27.53	-3.61	-233.13
EPS Growth (%)	55.28	0.18	-0.55	0.39	0.08	-0.10
Book Value Growth (%)	-63.63	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.49	-0.93	-3.78	-1.22	-6.53
Price / Book Value	2.85	1.20	0.90	1.27	0.52	2.13
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.57	0.35	0.13	-1.81	0.94	-3.67
Close Price ($)	0.36	0.63	1.48	3.86	2.05	11.91
High Price ($)	2.38	2.38	8.19	4.57	12.86	23.99
Low Price ($)	0.27	0.56	1.38	1.57	1.39	10.69
Market Cap ($ Cr)	46.96	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.38	0.51	0.47	0.12	0.10
Short term debt to equity ratio	--	0.07	0.02	0.07	0.02	0.01
Current Ratio	2.91	1.62	7.45	7.14	5.84	13.56
Quick Ratio	2.91	--	--	--	5.84	--
Interest Coverage	-6.60	-10.53	-14.14	-10.90	-50.78	-231.88

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	6.77	42.24	--
Asset Turnover	0.30	--	0.01	0.12	0.10	0.03
Receivable days	--	--	261.58	75.80	154.29	--
Inventory Days	--	--	--	0.00	0.00	--
Payable days	--	423.48	440.05	264.72	237.05	759.82
Cash Conversion Cycle	--	--	--	-188.92	-82.76	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.